BOLD

Boundless Bio, Inc. - Common Stock (BOLD)

About Boundless Bio, Inc. - Common Stock (BOLD)

Boundless Bio, Inc. is a clinical-stage oncology company, which is dedicated to unlocking a new paradigm in cancer therapeutics that addresses the significant unmet need in patients with oncogene amplified tumors by targeting extrachromosomal DNA. The company was founded by Vineet Bafna, Paul Mischel, Benjamin F. Cravatt, and Jonathan E. Lim on April 10, 2018 and is headquartered in La Jolla, CA.

Details

Daily high

$2.84

Daily low

$2.75

Price at open

$2.80

52 Week High

$3.16

52 Week Low

$0.96

Market cap

63.9M

Dividend yield

Volume

133,702

Avg. volume

93,011

P/E ratio

-.98

Boundless Bio, Inc. - Common Stock News